Triveni Bio
Watertown
About Triveni Bio
Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a genetics-driven precision medicine approach, the company aims to demonstrate proof-of-concept early in drug development by harnessing deep insights into genetic and mechanistic biology. The company's drug discovery platform aims to create targeted therapies for immunological and inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $207.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2024)
- Website: triveni.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/triveni-bio-20605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.